A randomized controlled superiority trial of 1 L (Plenvu) versus 2 L (Moviprep) polyethelene glycol plus ascorbate in a FIT-based colorectal cancer screening setting (PLEMO)
Søren Roepstorff, Thomas Bryrup, Morten Rasmussen
Springer Nature ·
2026-05-20
· DOI 10.1186/s12876-026-04948-6
The publisher did not provide an abstract — full text is available via the link below.
Søren Roepstorff, Thomas Bryrup, Morten Rasmussen. A randomized controlled superiority trial of 1 L (Plenvu) versus 2 L (Moviprep) polyethelene glycol plus ascorbate in a FIT-based colorectal cancer screening setting (PLEMO). // BMC Gastroenterology. – 2026. – DOI: 10.1186/s12876-026-04948-6. – URL: https://doi.org/10.1186/s12876-026-04948-6
Søren Roepstorff, Thomas Bryrup, & Morten Rasmussen (2026). A randomized controlled superiority trial of 1 L (Plenvu) versus 2 L (Moviprep) polyethelene glycol plus ascorbate in a FIT-based colorectal cancer screening setting (PLEMO). BMC Gastroenterology. https://doi.org/10.1186/s12876-026-04948-6
Søren Roepstorff, et al. “A randomized controlled superiority trial of 1 L (Plenvu) versus 2 L (Moviprep) polyethelene glycol plus ascorbate in a FIT-based colorectal cancer screening setting (PLEMO).” BMC Gastroenterology, 2026. doi:10.1186/s12876-026-04948-6.
@article{Roepstorff2026,
title = {A randomized controlled superiority trial of 1 L (Plenvu) versus 2 L (Moviprep) polyethelene glycol plus ascorbate in a FIT-based colorectal cancer screening setting (PLEMO)},
author = {Roepstorff, Søren and Bryrup, Thomas and Rasmussen, Morten},
journal = {BMC Gastroenterology},
year = {2026},
doi = {10.1186/s12876-026-04948-6},
url = {https://doi.org/10.1186/s12876-026-04948-6}
}